Acquisition of MDR phenotype by leukemic cells is associated with increased caspase-3 activity and a collateral

David Cerezo1, Miriam Lencina, Antonio J Ruiz-Alcaraz

  • 1Department of Biochemistry and Molecular Biology B and Immunology, University of Murcia, Murcia, Spain.

Insights

Multidrug-resistant (MDR) cancer cells overexpressing P-glycoprotein (P-gp) exhibit unexpected sensitivity to cold temperatures, leading to cell death. This P-gp-mediated cold sensitivity involves caspase-3 activation and offers potential new therapeutic avenues.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Multidrug resistance (MDR) in cancer, often mediated by P-glycoprotein (P-gp), is a major cause of chemotherapy failure.
  • P-gp extrudes chemotherapeutic agents and influences programmed cell death pathways.

Purpose of the Study:

  • To investigate the effect of cold stress on MDR tumor cells.
  • To explore the role of P-gp expression in MDR cell survival and death under cold conditions.
  • To elucidate the molecular mechanisms underlying P-gp-mediated cold sensitivity.

Main Methods:

  • Comparison of cold stress response in P-gp overexpressing MDR leukemic cells versus sensitive counterparts.
  • Transfection of parental cells with a P-gp-expressing plasmid.
  • Assessment of basal caspase-3 expression and activity at 37 °C.
  • Evaluation of caspase-3 inhibitor effects on cold-induced apoptosis.

Main Results:

  • MDR cells overexpressing P-gp showed hypersensitivity to cell death below 4 °C, unlike sensitive cells.
  • Transfection with P-gp conferred cold sensitivity to parental cells.
  • MDR cells exhibited increased basal caspase-3 activity at 37 °C.
  • Caspase-3 inhibition partially protected MDR cells from cold-induced apoptosis.

Conclusions:

  • P-gp expression is associated with collateral sensitivity to cold-induced cell death in MDR cancer cells.
  • Caspase-3 activity appears to be involved in the P-gp-mediated cold-induced apoptosis pathway.
  • These findings suggest novel therapeutic strategies targeting P-gp for cancer treatment.